Tag : Creatinine

Latest News

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

Newsemia
New research shows that adults with lupus who take the antimalarial drug, hydroxychloroquine, do not have any differences in their corrected QT (QTc) intervals, an...
Latest News

Researchers develop a unique method of identifying early signs of acute kidney injury

Newsemia
Researchers at the University of Liverpool have identified a unique method of identifying the early signs of a potentially serious condition known as Acute Kidney...
Latest News

North America Creatinine Measurement Market, 2020-2027: COVID-19 Impact and Regional Analysis by Product, Type, Sample Type, & End-User – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “North America Creatinine Measurement Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by Product; Type; Sample Type; End-User, and Country” report...
Pharma / Biotech

Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency.

Newsemia
Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency. Clin Ther. 2020 Aug 12;: Authors: Du P,...
Latest News

Cardiovascular disease in COVID-19

Newsemia
The current COVID-19 pandemic is a primarily respiratory illness, manifesting with severe hypoxia and often progressing to acute respiratory distress syndrome (ARDS) and death. However,...
Latest News

Large gap between norms and actual quality of primary care in Canadian kidney patients

Newsemia
Chronic kidney disease (CKD) is a condition commonly encountered in primary health care the world over. However, a new study published in JAMA Network on...
Latest News

Artificial intelligence can help accurately predict acute kidney injury in burn patients

Newsemia
Many burn victims suffer acute kidney injury (AKI), but early recognition of AKI remains challenging. Now an Artificial Intelligence / Machine Learning (AI/ML) model developed...
Latest News

Coming soon: New home blood-testing device for people with chronic illnesses

Newsemia
Université de Montréal’s Laboratory of Biosensors & Nanomachines, in partnership with Montreal company Nanogenecs Diagnostics, has just been awarded a 700 000$ NSERC ‘Idea to...
Latest News

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Newsemia
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy